DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies

Andrea L Reid1, Yimin Wang1, Adrienne Samani1

  • 1Division of Neurology, Department of Pediatrics, The University of Alabama at Birmingham and Children's of Alabama, Birmingham, AL 35294, USA.

Insights

The study reveals DOCK3

Area of Science:

  • Muscle biology
  • Cell signaling
  • Genetics

Background:

  • DOCK3, a guanine nucleotide exchange factor, regulates crucial cellular processes like migration and fusion.
  • A dysregulated miR-486/DOCK3 pathway was previously observed in dystrophin-deficient muscle, leading to DOCK3 overexpression.
  • The specific role of DOCK3 in skeletal muscle function and disease remains largely uncharacterized.

Purpose of the Study:

  • To elucidate the functional significance of DOCK3 in both healthy and dystrophic skeletal muscle.
  • To investigate the impact of DOCK3 deficiency on muscle pathology and differentiation.

Main Methods:

  • Utilized global Dock3 knockout (KO) mice and Duchenne muscular dystrophy mouse models.
  • Assessed muscle function and pathology in varying DOCK3 deficiency states.
  • Performed transcriptomic analysis on Dock3 KO muscles to identify molecular changes.

Main Results:

  • Haploinsufficiency of Dock3 ameliorated muscle pathologies in Duchenne muscular dystrophy mice.
  • Complete loss of Dock3 led to impaired muscle function and defective myogenic differentiation in adult mice.
  • Transcriptomic analysis showed reduced myogenic factors and differentiation pathways in Dock3 KO muscles.

Conclusions:

  • DOCK3 plays a critical role in maintaining skeletal muscle health and function.
  • DOCK3 is identified as a novel modulator of muscle differentiation and health.
  • These findings suggest DOCK3 as a potential therapeutic target for muscular dystrophy symptoms.